首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   36082篇
  免费   3183篇
  国内免费   1798篇
耳鼻咽喉   582篇
儿科学   510篇
妇产科学   821篇
基础医学   4223篇
口腔科学   573篇
临床医学   4255篇
内科学   6308篇
皮肤病学   815篇
神经病学   1960篇
特种医学   1205篇
外国民族医学   17篇
外科学   3660篇
综合类   4326篇
现状与发展   4篇
一般理论   7篇
预防医学   2353篇
眼科学   806篇
药学   3666篇
  31篇
中国医学   1697篇
肿瘤学   3244篇
  2024年   305篇
  2023年   610篇
  2022年   1181篇
  2021年   1556篇
  2020年   1188篇
  2019年   1171篇
  2018年   1292篇
  2017年   1104篇
  2016年   1050篇
  2015年   1554篇
  2014年   1903篇
  2013年   1892篇
  2012年   2668篇
  2011年   2805篇
  2010年   1792篇
  2009年   1332篇
  2008年   1928篇
  2007年   1836篇
  2006年   1861篇
  2005年   1825篇
  2004年   1330篇
  2003年   1270篇
  2002年   1092篇
  2001年   900篇
  2000年   824篇
  1999年   749篇
  1998年   458篇
  1997年   413篇
  1996年   335篇
  1995年   306篇
  1994年   275篇
  1993年   197篇
  1992年   327篇
  1991年   285篇
  1990年   219篇
  1989年   171篇
  1988年   193篇
  1987年   158篇
  1986年   124篇
  1985年   119篇
  1984年   84篇
  1983年   45篇
  1982年   25篇
  1981年   35篇
  1980年   22篇
  1979年   32篇
  1978年   24篇
  1977年   19篇
  1975年   18篇
  1973年   24篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
62.
63.
Proliferation, invasion, immortalization and metastasis are the main malignant characteristics of cancer. Previous studies have shown that high-intensity focused ultrasound (US), or HIFU, can induce irreversible damage both to breast cancer cells and to tumor blood vessels. However, light microscopy alone may not always show this clearly. In this study, molecular biologic techniques were used to examine any changes in molecular markers associated with malignant behavior after exposure to HIFU. A total of 48 women with breast cancer were randomized to a control group (mastectomy) and a HIFU group (HIFU followed by mastectomy). Immunohistochemical staining, messenger RNA (mRNA) in situ hybridization and telomere-repeat amplification protocol-enzyme-linked immunosorbent assay (TRAP-ELISA) techniques were used to detect tumor expression of proliferating cell nuclear antigen (PCNA), cell adhesion molecule CD44v6, matrix metalloproteinase-9 (MMP-9), erbB2 mRNA, and to measure telomerase activity in both groups. The results demonstrated that there were significant alterations in expression of PCNA, CD44v6, MMP-9, erbB2 mRNA, and a dramatic decrease in telomerase activity in the HIFU group. It is concluded that malignant tumor characteristics are arrested by HIFU, and that biologic factors are potential markers for assessing HIFU efficacy.  相似文献   
64.
目的:观察肺癌患者中西医结合治疗后其舌脉象参数变化情况,探讨舌脉象参数变化在肺癌患者中西医结合治疗过程中的临床意义。方法:于2015年1月至2016年4月,选取该阶段内我院采取中西医结合疗法治疗的50例肺癌患者作为此次研究的对象,分别于治疗前、治疗后1个月、治疗后2个月,采用舌脉象数字化分析仪对肺癌患者的舌象图片和关部脉图进行检测,比较治疗前、治疗后1个月、治疗后2个月患者的舌象参数、脉象参数。结果:与治疗前相比,治疗后1个月、治疗后2个月肺癌患者脉象参数中的PSR1明显增高(P0.05),PSR2明显降低(P0.05);与治疗后1个月相比,治疗后2个月肺癌患者脉象参数中的PSR1明显降低(P0.05),PSR2、PSR3均明显增高(P0.05);治疗前与治疗后相比,肺癌患者的脉象参数CSR1、CSR2、CSR3均未出现明显改变(P0.05)。与治疗前相比,治疗后1个月肺癌患者的舌象润燥指数、腐腻指数、裂纹指数均明显增高(P0.05),厚薄指数明显降低(P0.05);与治疗后1个月相比,治疗后2个月肺癌患者的裂纹指数明显降低(P0.05),厚薄指数明显增高(P0.05),润燥指数和腐腻指数未发生明显改变(P0.05)。结论:在肺癌患者采用中西医结合疗法治疗的过程中,舌脉象参数的变化可有效反映肺癌患者的中西医结合治疗效果,可作为中西医结合治疗肺癌的疗效评估指标。  相似文献   
65.
Prismatomeris connata was a kind of Rubiaceae plant for treatment of hepatitis, hepatic fibrosis and silicosis. Whereas, the effective components of Prismatomeris connata remains unexplored. The aim of this study was to investigate the inhibitory effects and mechanisms of Rubiadin isolated from Prismatomeris connata against HBV using HepG2.2.15 cells. The levels of hepatitis B surface antigen (HBsAg), hepatitis B e antigen (HBeAg), and hepatitis B core antigen (HBcAg) in the supernatants or cytoplasm were examined using by enzyme‐linked immunosorbent assay. HBV DNA was qualified q‐PCR. Rubiadin was isolated by silica gel column. The structure of the compound was elucidated by HPLC, FT‐IR, 1H‐NMR, 13C‐NMR and identified as 1,3‐Dihydroxy‐2‐methyl‐9, 10‐anthraquinone. Rubiadin significantly decreased HBeAg,HBcAg secretion level and inhibit HBV DNA replication. Rubiadin inhibits the proliferation of the cells and HBx protein expression in a dose‐dependent manner. The intracellular calcium concentration was significantly reduced. These results demonstrated that Rubiadin could inhibit HepG2.2.15 cells proliferation, reduce the level of HBx expression, and intracellular free calcium, which might become a novel anti‐HBV drug candidate.  相似文献   
66.
67.

Background and objectives

An ultrasound guided femoral nerve block is an established analgesic method in patients with a hip fracture. Elevated cytokine levels correlate with poor patient outcomes after surgery. Hence, the aim of the study was to describe the levels of tumor necrosis factor‐α after an ultrasound‐guided femoral nerve block in elderly patients having a femoral neck fracture.

Methods

A total of 32 patients were allocated into two treatment groups: 16 patients (femoral nerve block group; ultrasound‐guided femoral nerve block with up to 20 mL of 0.3 mL.kg?1 of 0.5% bupivacaine and intravenous tramadol) and 16 patients (standard management group; up to 3 mL of 0.9% saline in the femoral sheath and intravenous tramadol). Tumor necrosis factor‐α and visual analogue scale scores were evaluated immediately before the femoral nerve block and again at 4, 24, and 48 h after the femoral nerve block. All surgery was performed electively after 48 h of femoral nerve block.

Results

The femoral nerve block group had a significantly lower mean tumor necrosis factor‐α level at 24 (4.60 vs. 8.14, p < 0.001) and 48 h (5.05 vs. 8.56, p < 0.001) after the femoral nerve block, compared to the standard management group. The femoral nerve block group showed a significantly lower mean visual analogue scale score at 4 (3.63 vs. 7.06, p < 0.001) and 24 h (4.50 vs. 5.75, p < 0.001) after the femoral nerve block, compared to the standard management group.

Conclusions

Ultrasound‐guided femoral nerve block using 0.3 mL.kg?1 of 0.5% bupivacaine up to a maximum of 20 mL resulted in a significant lower tumor necrosis factor‐α level.  相似文献   
68.

Background

Ureteral stents have been widely used in kidney transplantation to prevent postoperative ureter-related complications such as ureteral stricture, ureteral obstruction, and ureteral leakage; however, a longer indwelling ureteral stent time corresponds to a greater risk of complications such as urinary tract infections. Currently, transplantation centers have not yet reached an agreement on the time to remove ureteral stents. Several randomized controlled trials (RCTs) have evaluated the optimal removal time for ureteral stents.

Objective

This meta-analysis was designed to evaluate and discuss the optimal removal time for ureteral stents after kidney transplantation.

Method

We used key words to search PubMed, Embase, and Cochrane Library and retrieve published articles. A total of 568 kidney transplantation patients from 5 RCTs were included in this meta-analysis. We collected information regarding postoperative complications related to indwelling stents, such as ureteral stricture, ureteral obstruction, ureteral leakage, and urinary tract infection, and evaluated whether early removal of ureteral stents (≤7 days) was superior to late removal (≥14 days).

Results

A significant difference was observed in the incidence of urinary tract infection between the early removal group and the late removal group (risk ratio [RR] = 0.43, 95% confidence interval [CI] [0.32, 0.59], P < .01). No significant between-group difference was observed in the incidence of major urological complications (MUCs) (RR = 1.87, 95% CI [0.45, 7.70], P > .05).

Conclusion

Early removal of ureteral stents of transplanted kidneys after kidney transplantation (≤7 days) did not significantly increase the incidence of postoperative MUCs (ureteral stricture, ureteral obstruction, and ureteral leakage) relative to late removal (≥14 days). Early removal may significantly reduce the incidence of postoperative urinary tract infection relative to late removal.  相似文献   
69.

Objectives

The score in the Model of End-stage Liver Disease, or MELD, is a good indicator of the survival in patients on the liver transplant waiting list. In this study, an analysis is performed on the benefits of liver transplant on those patients with a very high MELD score and who thus start from a very severe baseline state that could affect the surgical outcome.

Materials and methods

A prospective study was conducted on a cohort of 331 patients that received a liver transplant between 2002 and 2014. The patients were divided into 2 groups according to the MELD score (<28 vs ≥28), and differences in age, postoperative complications, stay in the intensive care unit (ICU), hospital stay, and survival were compared.

Results

Of the total of 331 patients, 21 (6.3%) had a MELD score ≥ 28. The mean age of the group with MELD score ≥ 28 was lower than the age in the group with MEDL score < 28 (42.5 vs 53.7 years; P < .0001). No significant increase was observed in postoperative complications. Although there were also no differences in survival, the group with MELD score ≥ 28 did have a longer stay in ICU and a longer hospital stay (with a mean of 6.7 days in ICU and 41.5 days admission vs 4.1 and 26.9, respectively).

Conclusions

A very high MELD score is associated with a longer stay in ICU and more days of hospital admission, although no differences were observed in postoperative complications or survival. Therefore, there does not seem to be any contraindication in transplantation in this group of patients.  相似文献   
70.

Background

Resistant cytomegalovirus (R-CMV) is an emerging problem in the renal transplantation population. The most frequent CMVs are high-resistance mutations (UL97 gene).

Methods

We describe our experience in management of R-CMV after renal transplant at our center (2012–2016).

Results

We encountered 3 cases of R-CMV infection after renal transplant (all primary infections). All 3 patients received induction therapy with corticosteroids, tacrolimus, and mycophenolate mofetil. The first patient (basiliximab induction, preemptive CMV) developed CMV replication on day +53, which responded poorly both to standard-dose valganciclovir (vGCV) and high-dose ganciclovir (GCV) (creatinine clearance [CrCl] >70 mL/min; vGCV 900 mg twice daily for 50 days and GCV 7.5 mg/kg twice daily for 8 days). Hematologic toxicity occurred. The R-CMV test was positive and foscarnet (FOS) was initiated (90 mg/kg twice daily for 21 days). The second patient presented CMV infection (day +30, thymoglobulin induction, CMV prophylaxis), which was not controlled with the high dose (CrCl 23 mL/min; GCV 3.5 mg/kg twice daily and vGCV 900 mg twice daily), resulting in severe neutropenia. R-CMV was detected and FOS initiated (FOS 50 mg/kg twice daily for 7 days and 50 mg/kg every 2 days for 13 days). The third patient's infection occurred on day +22 (basiliximab induction, preemptive CMV). Standard-dose vGCV was uneffective (CrCl >70 mL/min, vGCV 900 mg twice daily) and it did not respond to the high dose (GCV 7.5 mg/kg twice daily and vGCV 2700 mg/d). Moderate hematologic toxicity occurred. R-CMV was diagnosed and FOS treatment begun (FOS 70 mg/kg per day for 2 weeks).

Conclusions

Resistant CMV infection may be severe due to viral infection and side effects of high-dose antiviral treatment. We presented 3 cases requiring the use of FOS in the absence of response or toxic effects from the usual treatment, with an optimal sustained response (temporary in case 2) and without serious side effects.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号